Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Epinephrine; Lidocaine Hydrochloride Patent Expiration

Epinephrine; Lidocaine Hydrochloride was first introduced by Fresenius Kabi Usa Llc in its drug Xylocaine W/ Epinephrine on Approved Prior to Jan 1, 1982. Other drugs containing Epinephrine; Lidocaine Hydrochloride are Xylocaine Dental With Epinephrine, Lidocaine Hydrochloride And Epinephrine, Iontocaine, Lidosite Topical System Kit. 19 different companies have introduced drugs containing Epinephrine; Lidocaine Hydrochloride.


Epinephrine; Lidocaine Hydrochloride Patents

Given below is the list of patents protecting Epinephrine; Lidocaine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lidosite Topical System Kit US6635045 Electrodes and method for manufacturing electrodes for electrically assisted drug delivery Jun 29, 2021

(Expired)

 Vyteris
Lidosite Topical System Kit US6629968 Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode Jun 30, 2020

(Expired)

 Vyteris
Lidosite Topical System Kit US5246418 Iontophresis system having features for reducing skin irritation Sep 30, 2013

(Expired)

 Vyteris
Lidosite Topical System Kit US5873850 Locking and disfiguring mechanism for an iontophoretic system Sep 30, 2013

(Expired)

 Vyteris
Lidosite Topical System Kit US6377847 Iontophoretic drug delivery device and reservoir and method of making same Sep 30, 2013

(Expired)

 Vyteris
Lidosite Topical System Kit US6385488 Circuits for increasing the reliability of an iontophoretic system Sep 30, 2013

(Expired)

 Vyteris
Lidosite Topical System Kit US6862473 Iontophoretic drug delivery device and reservoir and method of making same Sep 30, 2013

(Expired)

 Vyteris



Epinephrine; Lidocaine Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Epinephrine; Lidocaine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Epinephrine; Lidocaine Hydrochloride. The first generic version for Epinephrine; Lidocaine Hydrochloride was by Dell Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by B Braun Medical Inc and was approved on Sep 8, 2021.

Given below is the list of companies who have filed for Epinephrine; Lidocaine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.


1. ABBOTT

Abbott Laboratories Pharmaceutical Products Div has filed for 1 generic for Epinephrine; Lidocaine Hydrochloride. This 0.01mg/ml;1% version comes by the name LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE. Given below are the details of the strengths of this generic introduced by Abbott.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01MG/ML; 1%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982


Manufacturing Plant Locations
New

Abbott's manufacturing plants are situated in 7 countries - United States, Netherlands, United Kingdom, Norway, Germany, France, Ireland. Given below are the details of these plant locations as well as the firm names of Abbott as present at those locations.

Country City Firm Name
United States
Scarborough Abbott Diagnostics Scarborough, Inc.
Barceloneta Abbott Diagnostics International, Ltd.
Alameda Abbott Diabetes Care, Inc.
Plymouth Abbott
Clearwater ABBOTT BLACKSTONE CO.
Barceloneta Abbott Healthcare (Puerto Rico) Ltd.
Netherlands
Olst Abbott Biologicals BV
United Kingdom
Witney ABBOTT DIABETES CARE LIMITED
Norway
Oslo Abbott Diagnostics Technologies AS
Germany
Wiesbaden Abbott GmbH
France
Chatillon Sur Chalaronne Abbott Healthcare SAS
Ireland
Sligo Abbott Ireland Limited
Cootehill ABBOTT IRELAND LIMITED
Sligo Abbott Ireland
Co. Longford Abbott Ireland Diagnostics Division
Donegal ABBOTT IRELAND DIABETES CARE





2. B BRAUN MEDICAL INC

B Braun Medical Inc has filed for 1 generic for Epinephrine; Lidocaine Hydrochloride. This 0.005mg/ml;1.5% version comes by the name LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE. Given below are the details of the strengths of this generic introduced by B Braun Medical Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.005MG/ML; 1.5%

injectable Prescription INJECTION AP Sep 8, 2021


Manufacturing Plant Locations
New

B Braun Medical Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of B Braun Medical Inc as present at those locations.

Country City Firm Name
United States
Breinigsville B Braun Medical Inc





3. BEL MAR

Bel Mar Laboratories Inc has filed for 2 different strengths of generic version for Epinephrine; Lidocaine Hydrochloride. All of these versions come by the name LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE. Given below are the details of the strengths of this generic introduced by Bel Mar.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01MG/ML; 2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
0.01MG/ML; 1%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





4. BELMORA LLC

Belmora Llc has filed for 2 different strengths of generic version for Epinephrine; Lidocaine Hydrochloride. All of these versions come by the name LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE. Given below are the details of the strengths of this generic introduced by Belmora Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01MG/ML; 2%

injectable Discontinued INJECTION N/A Oct 19, 1983
0.02MG/ML; 2%

injectable Discontinued INJECTION N/A Oct 19, 1983


Manufacturing Plant Locations
New

Belmora Llc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Belmora Llc as present at those locations.

Country City Firm Name
United States
Arlington Belmora LLC





5. CARLISLE

Carlisle Laboratories Inc has filed for 2 different strengths of generic version for Epinephrine; Lidocaine Hydrochloride. All of these versions come by the name ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE. Given below are the details of the strengths of this generic introduced by Carlisle.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.02MG/ML; 2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
0.01MG/ML; 2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982


Manufacturing Plant Locations
New

Carlisle's manufacturing plants are situated in 2 countries - United States, China. Given below are the details of these plant locations as well as the firm names of Carlisle as present at those locations.

Country City Firm Name
United States
Carlisle Carlisle Regional Medical Center
Kent Carlisle Interconnect Technolog
China
Dongguan CARLISLE MEDICAL TECHNOLOGIES(DONGGUAN) CO., LTD





6. DELL LABS

Dell Laboratories Inc has filed for 2 different strengths of generic version for Epinephrine; Lidocaine Hydrochloride. All of these versions come by the name LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE. Given below are the details of the strengths of this generic introduced by Dell Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01MG/ML; 2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
0.01MG/ML; 1%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





7. EASTMAN KODAK

Eastman Kodak Co has filed for 2 different strengths of generic version for Epinephrine; Lidocaine Hydrochloride. All of these versions come by the name LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE. Given below are the details of the strengths of this generic introduced by Eastman Kodak.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01MG/ML; 2%

injectable Discontinued INJECTION N/A Feb 26, 1993
0.02MG/ML; 2%

injectable Discontinued INJECTION N/A Feb 26, 1993





8. HOSPIRA

Hospira Inc has filed for 7 different strengths of generic version for Epinephrine; Lidocaine Hydrochloride. All of these versions come by the name LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.005MG/ML; 1.5%

injectable Prescription INJECTION AP Jun 21, 1988
0.005MG/ML; 2%

injectable Prescription INJECTION AP Jun 21, 1988
0.005MG/ML; 0.5%

injectable Prescription INJECTION AP Jun 21, 1988
0.01MG/ML; 1%

injectable Prescription INJECTION AP Jun 21, 1988
0.01MG/ML; 2%

injectable Discontinued INJECTION N/A May 12, 2008
0.005MG/ML; 1%

injectable Discontinued INJECTION N/A Jun 21, 1988
0.02MG/ML; 2%

injectable Discontinued INJECTION N/A May 12, 2008


Manufacturing Plant Locations
New

Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.

Country City Firm Name
Australia
Mulgrave Hospira Australia Pty Ltd.
United States
Rocky Mount Hospira, Inc.
Clayton Hospira, Inc.
Morgan Hill Hospira Inc
Mcpherson Hospira, Inc., A Pfizer Company
Lake Forest Hospira Inc
Pleasant Prairie Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
Dominican Republic (the)
Haina, San Cristobal Hospira, Ltd.





9. INTL MEDICATION

International Medication System has filed for 1 generic for Epinephrine; Lidocaine Hydrochloride. This 0.01mg/ml;1% version comes by the name LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE. Given below are the details of the strengths of this generic introduced by Intl Medication.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01MG/ML; 1%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





10. PHARMATON

Pharmaton Ltd has filed for 2 different strengths of generic version for Epinephrine; Lidocaine Hydrochloride. All of these versions come by the name LIDOCATON. Given below are the details of the strengths of this generic introduced by Pharmaton.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01MG/ML; 2%

injectable Discontinued INJECTION N/A Aug 17, 1983
0.02MG/ML; 2%

injectable Discontinued INJECTION N/A Aug 17, 1983





11. SEPTODONT

Septodont Inc has filed for 2 different strengths of generic version for Epinephrine; Lidocaine Hydrochloride. All of these versions come by the name OCTOCAINE. Given below are the details of the strengths of this generic introduced by Septodont.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.02MG/ML; 2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
0.01MG/ML; 2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982


Manufacturing Plant Locations
New

Septodont's manufacturing plants are situated in 2 countries - France, United States. Given below are the details of these plant locations as well as the firm names of Septodont as present at those locations.

Country City Firm Name
France
St Maur Des Fosses Septodont
United States
Louisville Septodont Inc.





12. WATSON LABS

Watson Laboratories Inc has filed for 2 different strengths of generic version for Epinephrine; Lidocaine Hydrochloride. All of these versions come by the name LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01MG/ML; 1%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
0.01MG/ML; 2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982





13. WEST-WARD PHARMS INT

West-ward Pharmaceuticals International Ltd has filed for 2 different strengths of generic version for Epinephrine; Lidocaine Hydrochloride. All of these versions come by the name LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE. Given below are the details of the strengths of this generic introduced by West-ward Pharms Int.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01MG/ML; 1%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
0.01MG/ML; 2%

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982